ICON PLC

IE

ICLR

Health Care

297.93 ₽

Current price

Hold
297.93 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    55 / 240

  • Position in country

    79 / 187

  • Return on Assets, %

    3.5

    -2.7

  • Net income margin, %

    10.4

    -6.7

  • EBITDA margin, %

    20.5

    5.6

  • Debt to Equity, %

    40.8

    15.1

  • Intangible assets and goodwill, %

    75.7

    4.7

  • Revenue CAGR 3Y, %

    42.6

    12.8

  • Total Equity change 1Y, %

    8.7

    -2.4

  • Revenue Y, % chg

    4.8

    0

  • P/E

    41.3

    32.1

  • P/BV

    2.7

    2

  • P/S

    3.1

    4.1

  • EV/S

    3.5

    3.6

  • EV/EBITDA

    17.5

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    16

    48.9

  • Forward P/E

    19.7

    25.5

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    10.1

Get an analytical review of this company

Competitors

Ranks

  • Lonza Group AG

    00%

  • Samsung Biologics Co Ltd

    00%

  • ICON PLC

    00%

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Sartorius Stedim Biotech SA

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Ireland; Republic of

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    25243.4

  • Ticker

    ICLR.O

  • ISIN

    IE0005711209

  • IPO date

    1998-05-15

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-23

  • Date fact. publication of reports

    2023-12-31

Company Description

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.